- 100 free trades signup offer
- Easy-to-use platform
- Low fees
- Student and young investor discounts
Evotec SE is a drug manufacturers - specialty & generic business based in the US. Evotec SE shares (EVO) are listed on the NASDAQ and all prices are listed in US Dollars.
Its last market close was $4.61 – a decrease of 1.71% over the previous week. Evotec SE employs 5,007 staff and has a trailing 12-month revenue of around $777.1 million.Our top picks for where to buy Evotec SE ADR stock
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
- 6% cash rebate plus $2,200 in trading perks
- Low transaction fees
- Easy-to-use app
How to buy Evotec SE stock
- Choose a stock trading platform. Compare investment platforms.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – EVO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Evotec SE stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
Evotec SE stock price (NASDAQ: EVO)
Use our graph to track the performance of EVO stocks over time.Evotec SE stocks at a glance
Latest market close | $4.61 |
---|---|
52-week range | $2.85 - $12.00 |
50-day moving average | $3.55 |
200-day moving average | $5.15 |
Wall St. target price | $6.20 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-0.52 |
Is it a good time to buy Evotec SE stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Evotec SE price performance over time
Historical closes compared with the close of $4.71 from 2024-12-05
1 week (2024-11-29) | 0.43% |
---|---|
1 month (2024-11-07) | 10.82% |
3 months (2024-09-06) | 40.18% |
6 months (2024-06-07) | -1.46% |
1 year (2023-12-07) | -52.09% |
---|---|
2 years (2022-12-07) | -43.32% |
3 years (2021-12-07) | 22.99 |
5 years (2019-12-05) | 11.155 |
Is Evotec SE stock undervalued or overvalued?
Valuing Evotec SE stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Evotec SE's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Evotec SE's EBITDA
Evotec SE's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $15.9 million.
The EBITDA is a measure of a Evotec SE's overall financial performance and is widely used to measure a its profitability.
Evotec SE financials
Revenue TTM | $777.1 million |
---|---|
Gross profit TTM | $151.5 million |
Return on assets TTM | -1.77% |
Return on equity TTM | -16.25% |
Profit margin | -22.05% |
Book value | $5.46 |
Market Capitalization | $1.7 billion |
TTM: trailing 12 months
Evotec SE stock dividends
We're not expecting Evotec SE to pay a dividend over the next 12 months.
Have Evotec SE's stocks ever split?
Evotec SE's stocks were split on a 4:1 basis on 19 October 2021 . So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Evotec SE stocks – just the quantity. However, indirectly, the new 75% lower stock price could have impacted the market appetite for Evotec SE stocks, which in turn could have impacted Evotec SE's stock price.
Evotec SE stock price volatility
Over the last 12 months, Evotec SE's stocks have ranged in value from as little as $2.85 up to $11.9999. A popular way to gauge a stock's volatility is its "beta."
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evotec SE's is 0.984. This would suggest that Evotec SE's stocks are less volatile than average (for this exchange).
Evotec SE overview
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health. It has collaboration agreements with SK bioscience, JingXin, Carrick Therapeutics, Sernova, Topas Therapeutics, Exscientia, CONBA Group, Centrexion, Sanofi/NIH, Kazia Therapeutics, Bristol Myers Squibb, Topas Therapeutics, Immunitas, Exscientia, and Bayer; and Inserm, the French National Institute of Health and Medical Research, Lille University Hospital, and Inserm Transfert to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases, as well as collaboration with CHDI Foundation, Inc.; and a strategic partnership with Dewpoint Therapeutics to advance its portfolio targeting biomolecular condensates as a novel domain for therapeutic intervention towards the clinic, as well as research collaboration with Pfizer for metabolic and infectious diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany..
Frequently asked questions
What percentage of Evotec SE is owned by institutions?Currently 2.197% of Evotec SE stocks are held by institutions. How many people work for Evotec SE?
Latest data suggests 5,007 work at Evotec SE. When does the fiscal year end for Evotec SE?
Evotec SE's fiscal year ends in December. Where is Evotec SE based?
Evotec SE's address is: Essener Bogen 7, Hamburg, Germany, 22419 What is Evotec SE's ISIN number?
Evotec SE's international securities identification number is: US30050E1055
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…What are stocks?
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
Read more…More guides on Finder
-
How to buy Raytheon Technologies (RTX) stocks
Steps to owning and managing Raytheon Technologies Corp, with 24-hour and historical pricing before you buy.
-
How to buy Gildan Activewear (GIL) stocks
Steps to owning and managing Gildan Activewear Inc., with 24-hour and historical pricing before you buy.
-
Best renewable energy stocks
These are the best renewable energy stocks to buy now in Canada.
-
Best stocks to buy right now in Canada
Finder’s unique algorithm found the 20 best TSX stocks to buy right now.
-
How to buy Manchester United stock in Canada
Steps to owning and managing MANU stock, with 24-hour and historical pricing before you buy.
-
How to buy IL Makiage stock in Canada when it goes public
Everything we know about the IL Makiage IPO plus information on how to buy in.
-
How to buy ByteDance stock in Canada when it goes public
Everything we know about the ByteDance IPO plus information on how to buy in.
-
How to buy Auvik Networks stock in Canada when it goes public
Everything we know about the Auvik Networks IPO plus information on how to buy in.
-
How to buy goPuff stock in Canada when it goes public
Everything we know about the goPuff IPO plus information on how to buy in.
-
How to buy Universal Music Group (UMG) stock from Canada
If you live in Canada, you need a broker that provides access to foreign investments to buy Universal Music Group stock.